Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A myeloid-derived suppressor cell (MDSC) modulator is any molecule, drug, or biological agent that alters the development, function, recruitment, or survival of MDSCs. MDSCs are a heterogeneous population of immature myeloid cells with potent immunosuppressive properties. They play critical roles in regulating immune responses in cancer and other pathological conditions by inhibiting T cell activity and promoting tumor progression. Therapeutic strategies include inhibiting MDSCs in cancer to enhance anti-tumor immunity and enhancing MDSC function in autoimmunity and transplantation to suppress excessive immune responses.
Varies depending on the specific modulator; includes inhibition of STAT3/C/EBPβ signaling, blockade of MDSC recruitment, inhibition of MDSC suppressive function, promotion of MDSC differentiation, modulation of ARG1/iNOS activity, modulation of cytokine secretion.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myeloid-Derived Suppressor Cell Modulator.